HuGE Literature Finder
Records
1
-
9
Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
Germline TP53 mutational spectrum in French Canadians with breast cancer. BMC medical genetics 2015 16 24. Arcand Suzanna L, Akbari Mohammed R, Mes-Masson Anne-Marie, Provencher Diane, Foulkes William D, Narod Steven A, Tonin Patricia |
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
Routine TP53 testing for breast cancer under age 30: ready for prime time? Familial cancer 2012 Aug . McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D |
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa |
Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families. Breast cancer research and treatment 2008 Apr 108 (3): 399-408. Arcand Suzanna L, Maugard Christine M, Ghadirian Parviz, Robidoux André, Perret Chantal, Zhang Phil, Fafard Eve, Mes-Masson Anne-Marie, Foulkes William D, Provencher Diane, Narod Steven A, Tonin Patricia |
CHEK2 1100delC is not a risk factor for male breast cancer population. International journal of cancer. Journal international du cancer 2004 Jan 108 (3): 475-6. Syrjäkoski Kirsi, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli |
Mutation analysis of the CHK2 gene in families with hereditary breast cancer. British journal of cancer 2001 Jul 85 (2): 209-12. Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: